Md. Arifuzzaman
Md. Arifuzzaman has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Naznin Akhtar
Institute of Tissue Banking and Biomaterial Research, Atomic Energy Research Establishment, Dhaka, Bangladesh
3 shared publications - Sikder M. Asaduzzaman
Institute of Tissue Banking and Biomaterial Research, Atomic Energy Research Establishment (AERE), Savar, Dhaka 1349, Bangladesh
3 shared publications - Ayesha Siddika
Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, Bangladesh
2 shared publications - Farzana Diba
Institute of Tissue Banking and Biomaterial Research Atomic Energy Research Establishment (AERE) Savar Dhaka-1349 Bangladesh
2 shared publications - Md. Liakat Hossain2 shared publications
- Md. Zahid Hasan2 shared publications
Latest Publications
- 22 January 2024
- Published by Walter de Gruyter GmbH in Journal of Polymer Engineering
- Vol. 44 (3) , 211-222
Physically cross-linked scaffold composed of hydroxyapatite-chitosan-alginate-polyamide has potential to trigger bone regeneration in craniofacial defect
Recently, the fabrication of a scaffold from biomaterials has been increased due to the lack of adequate natural bone for grafting. In this study, hydroxyapatite-chitosan-alginate-polyamide (HCAP) synthetic scaffold was fabricated using the thermally induced phase separation (TIPS) technique. The scaffold was cross-linked with either a chemical cross-linker (calcium chloride, 2-hydroxyethyl methacrylate (HEMA), or glutaraldehyde (GTA)) or a physical cross-linker (gamma irradiation (IR)) resulting in scaffolds HCAP-CaCl2, HCAP-HEMA, HCAP-GTA, and HCAP-IR, respectively. The cross-linked scaffolds were characterized based on physicochemical properties, cytotoxicity, and biocompatibility. HCAP-GTA showed the highest density and the lowest swelling ratio and biodegradation rate closely matching with those of the HCAP-IR. Porosity and density of the HCAP, HCAP-IR, and HCAP-GTA scaffolds were 92.14, 87.26, and 83.33 %, and 0.241, 0.307, and 0.335 g/cm3, respectively. The swelling ratio for the same scaffolds was 149, 110, and 108 % after 72 h of observation. Brine shrimp cytotoxicity and RBC biocompatibility assay confirmed the non-toxic nature of HCAP-IR and HCAP-GTA scaffolds. The HCAP-IR scaffold was tested for bone regeneration in the rabbit mandible defect model. Histological analysis revealed the regeneration of new bone and restoration of bone defect at the site of injury. These findings indicate that radiation induced physically cross-linked HCAP scaffold could be used as an alternative in bone defect replacement therapy.
- 22 January 2024
- Published by Walter de Gruyter GmbH in Journal of Polymer Engineering
- Vol. 44 (3) , 211-222
Physically cross-linked scaffold composed of hydroxyapatite-chitosan-alginate-polyamide has potential to trigger bone regeneration in craniofacial defect
Recently, the fabrication of a scaffold from biomaterials has been increased due to the lack of adequate natural bone for grafting. In this study, hydroxyapatite-chitosan-alginate-polyamide (HCAP) synthetic scaffold was fabricated using the thermally induced phase separation (TIPS) technique. The scaffold was cross-linked with either a chemical cross-linker (calcium chloride, 2-hydroxyethyl methacrylate (HEMA), or glutaraldehyde (GTA)) or a physical cross-linker (gamma irradiation (IR)) resulting in scaffolds HCAP-CaCl2, HCAP-HEMA, HCAP-GTA, and HCAP-IR, respectively. The cross-linked scaffolds were characterized based on physicochemical properties, cytotoxicity, and biocompatibility. HCAP-GTA showed the highest density and the lowest swelling ratio and biodegradation rate closely matching with those of the HCAP-IR. Porosity and density of the HCAP, HCAP-IR, and HCAP-GTA scaffolds were 92.14, 87.26, and 83.33 %, and 0.241, 0.307, and 0.335 g/cm3, respectively. The swelling ratio for the same scaffolds was 149, 110, and 108 % after 72 h of observation. Brine shrimp cytotoxicity and RBC biocompatibility assay confirmed the non-toxic nature of HCAP-IR and HCAP-GTA scaffolds. The HCAP-IR scaffold was tested for bone regeneration in the rabbit mandible defect model. Histological analysis revealed the regeneration of new bone and restoration of bone defect at the site of injury. These findings indicate that radiation induced physically cross-linked HCAP scaffold could be used as an alternative in bone defect replacement therapy.
- Open Access
- 15 October 2018
- Published by MDPI AG in Preprints.org
Human Amniotic Membrane Preparation, Preservation and Clinical Application Using Various Techniques for the Treatment of Ophthalmic Dysfunctions
The aim of this study is to emphasize on the clinical uses of amniotic membrane (AM) in multiple ocular disorders. AM possesses many properties including promotion of epithelialization, anti-fibrotic, anti-apoptotic, anti-angiogenic properties. Epithelial wound healing on the eye surface is promoted due to several epidermal and keratocyte growth factors as well as by its anti-inflammatory and anti-scarring effects due to interleukin-10, interleukin-1 receptor antagonists and inhibition of transforming growth factor- beta (TGF-β) signal transduction by AM in the corneal and conjunctival fibroblasts respectively. It plays a crucial role by functioning as a substitute of basement membrane (BM) and as a temporary graft material. It is not only being used as an eye graft but also its extract can be used as an eye drop for corneal and external eye diseases. So its proper preparation, preservation and clinical application can bring a revolutionary change in the treatment of different ocular disorders.
- 15 October 2018
- Published by MDPI AG in Preprints.org
Open AccessHuman Amniotic Membrane Preparation, Preservation and Clinical Application Using Various Techniques for the Treatment of Ophthalmic Dysfunctions
The aim of this study is to emphasize on the clinical uses of amniotic membrane (AM) in multiple ocular disorders. AM possesses many properties including promotion of epithelialization, anti-fibrotic, anti-apoptotic, anti-angiogenic properties. Epithelial wound healing on the eye surface is promoted due to several epidermal and keratocyte growth factors as well as by its anti-inflammatory and anti-scarring effects due to interleukin-10, interleukin-1 receptor antagonists and inhibition of transforming growth factor- beta (TGF-β) signal transduction by AM in the corneal and conjunctival fibroblasts respectively. It plays a crucial role by functioning as a substitute of basement membrane (BM) and as a temporary graft material. It is not only being used as an eye graft but also its extract can be used as an eye drop for corneal and external eye diseases. So its proper preparation, preservation and clinical application can bring a revolutionary change in the treatment of different ocular disorders.
- Open Access
- 15 October 2018
- Published by MDPI AG in Preprints.org
Human Amniotic Membrane Preparation, Preservation and Clinical Application Using Various Techniques for the Treatment of Ophthalmic Dysfunctions
The aim of this study is to emphasize on the clinical uses of amniotic membrane (AM) in multiple ocular disorders. AM possesses many properties including promotion of epithelialization, anti-fibrotic, anti-apoptotic, anti-angiogenic properties. Epithelial wound healing on the eye surface is promoted due to several epidermal and keratocyte growth factors as well as by its anti-inflammatory and anti-scarring effects due to interleukin-10, interleukin-1 receptor antagonists and inhibition of transforming growth factor- beta (TGF-β) signal transduction by AM in the corneal and conjunctival fibroblasts respectively. It plays a crucial role by functioning as a substitute of basement membrane (BM) and as a temporary graft material. It is not only being used as an eye graft but also its extract can be used as an eye drop for corneal and external eye diseases. So its proper preparation, preservation and clinical application can bring a revolutionary change in the treatment of different ocular disorders.
- 15 October 2018
- Published by MDPI AG in Preprints.org
Open AccessHuman Amniotic Membrane Preparation, Preservation and Clinical Application Using Various Techniques for the Treatment of Ophthalmic Dysfunctions
The aim of this study is to emphasize on the clinical uses of amniotic membrane (AM) in multiple ocular disorders. AM possesses many properties including promotion of epithelialization, anti-fibrotic, anti-apoptotic, anti-angiogenic properties. Epithelial wound healing on the eye surface is promoted due to several epidermal and keratocyte growth factors as well as by its anti-inflammatory and anti-scarring effects due to interleukin-10, interleukin-1 receptor antagonists and inhibition of transforming growth factor- beta (TGF-β) signal transduction by AM in the corneal and conjunctival fibroblasts respectively. It plays a crucial role by functioning as a substitute of basement membrane (BM) and as a temporary graft material. It is not only being used as an eye graft but also its extract can be used as an eye drop for corneal and external eye diseases. So its proper preparation, preservation and clinical application can bring a revolutionary change in the treatment of different ocular disorders.